aod9604 stimulates lipolysis AOD-9604 AOD 9604 – Calibrate IV

At Nuviva, we understand that weight loss isnt one-size-fits-all

Liraglutide paved the way for GLP-1 therapies in obesity treatment, but most patients and clinicians now prefer semaglutide or tirzepatide because of stronger results and easier dosing

2009 Feb 1;89(2):693S-696S

Researchers and clinicians have studied its potential applications in body recomposition, stubborn fat reduction, and metabolic support, particularly in individuals who have not responded adequately to diet and exercise interventions alone

Adverse events included elevated heart rate (mean increase of 79 bpm), dry mouth, insomnia, and mild hypertension